Four months, three doses
What iterating a cytotoxicity study taught me about patience and evidence.
Short pieces on what I've built, tested and learned, plus a series explaining new treatments in plain language.
What iterating a cytotoxicity study taught me about patience and evidence.
Turning ANSYS results into a VR scene that patients and clinicians can both read.
Three ways to sharpen an X-ray, and why over-sharpening is dangerous.
What 93% agreement and a kappa of 0.90 tell you, and what they don't.
A recurring series on emerging treatments: gene editing, cell therapy and tissue engineering.